• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Valiant Laboratories Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting

    11-02-2026 | 04:45 pm

    Valiant Labs' Board approved Q3 & 9-month consolidated financials for Dec 31, 2025. Quarterly revenue was ₹52.46 Cr, reporting a net loss of ₹7.06 Cr. For the nine months, revenue hit ₹145.49 Cr with a net loss of ₹5.04 Cr.

    No comments yet. Be the first to comment!

    All announcements from Valiant Laboratories Limited